Citadel Advisors
IFRX icon

Citadel Advisors’s InflaRx IFRX Stock Holding History

Citadel Advisors’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.7K Buy
+12,800
New +$24.1K ﹤0.01% 13312
2025
Q2 		– Sell
-2,200
Closed -$2.24K – 13683
2025
Q1 		$2.24K Buy
2,200
+100
+5% +$189 ﹤0.01% 14052
2024
Q4 		$5.19K Buy
+2,100
New +$4.04K ﹤0.01% 13881
2024
Q1 		– Sell
-5,600
Closed -$9.13K – 14978
2023
Q4 		$9.13K Sell
5,600
-2,600
-32% -$4.46K ﹤0.01% 13172
2023
Q3 		$24.4K Sell
8,200
-13,500
-62% -$51.4K ﹤0.01% 12458
2023
Q2 		$96.8K Buy
21,700
+20,600
+1,873% +$92.2K ﹤0.01% 10993
2023
Q1 		$2.13K Sell
1,100
-16,400
-94% -$35.4K ﹤0.01% 14197
2022
Q4 		$54.3K Buy
+17,500
New +$44.6K ﹤0.01% 12029
2021
Q3 		– Sell
-10,600
Closed -$31K – 14195
2021
Q2 		$31K Buy
+10,600
New +$35.2K ﹤0.01% 13477

Other funds holding IFRX

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Citadel Advisors's IFRX Position: Q2 2026 in Review

Citadel Advisors increased its InflaRx (IFRX) stake by 435% in Q2 2026, buying an estimated $213K and bringing the position to 139,290 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #11026.

Citadel Advisors first reported a position in IFRX in Q1 2018 and has held it in 26 quarters since. The position peaked at $6.13M in Q2 2018. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Citadel Advisors held 139,290 shares of InflaRx worth $312K as of Q2 2026.
  • Citadel Advisors bought 113,253 InflaRx shares in Q2 2026, an estimated $213K.
  • InflaRx made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11026 holding.
  • Citadel Advisors first reported a position in InflaRx in Q1 2018 and has held it in 26 quarters since.
  • Citadel Advisors's InflaRx position peaked at $6.13M in Q2 2018.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.